ALS trials
Have you ever considered participating in a clinical trial (study) and thus contributing to medical research?
Clinical trials: between facts and fiction - Click here
What is new in the treatment of ALS? - Click here
Clinical trial - Information for the patient (BeCRO).pdf
Info experimental studies
Clinical trials in Belgium...
Orphazyme Arimoclomol (ORARIALS-01) study Active but not recruiting anymore
Biogen SOD1 ASO study Active but not recruiting anymore
Biogen Methodology study Active but not recruiting anymore
PESA study Active and recruiting
PYRAMID study Active and recruiting
REFALS - Levosimendan (ODM-109) Active but not recruiting anymore
Clinical trials abroad in collaboration with the league
| PRODUCT | STATUS | END DATE | RESPONSIBLE FIRM, UNIV, CLINIC OR COUNTRY |
| AMX0035 | Completed | 12/2019 ... | Amylyx |
| Antiretroviral | Recruiting | 02/2022 | NINDS |
| Arimoclomol | Active Not Recruiting | 01/2021 | Orphazyme |
| AT-1501 | Recruiting | TDI Anexilis | |
| Autologe Stamcellen | Mayo Clinic, Arabia, Israel, Iran, India, Poland, Spain, Czech, Brasil | ||
| Allogene Stamcellen | TCA Cellular Therapy LLC, Corestem en univs | ||
| AstroRx | Recruiting | 12/2020 | Kadimastem |
| Cannabinoids | Recruiting | 01/2021 | Australia |
| C9-antisense BIIB078 | Active Not Recruiting | 07/2022 | Biogen/Ionis |
| CU(II)ATSM | Recruiting | 12/2020 | Coll Med Dev Australia |
| Deferiprone | Recruiting | 04/2022 | France |
| Fasudil | Recruiting | 10/2021 | Germany |
| Foetale stamcellen (NSI-566) | Active Not Recruiting | 12/2016 ... | Seneca Biopharma (formerly Neuralstem) |
| GDNF | Active Not Recruiting | 10/2019 ... | Cedars Sinai |
| Ibudilast (MN-166) | Recruiting | 12/2024 | MediciNova |
| IC14 | Discontinued | 12/2020 | Australia and US |
| Interleukine 2 | Recruiting | 03/2020 ... | Univ Nîmes, France and UK |
| Levosimendan (ODM-109) | Active Not Recruiting | 10/2020 | Orion |
| Masitinib | Not Yet Recruiting | 09/2022 | AB Science |
| Memantine | Recruiting | 10/2020 | Kansas |
| Methylcobalamin | Recruiting | 03/2020 ... | Eisai Japan |
| Mexiletine 2 | Completed | 12/2018 ... | Univ Washington |
| Novel Outcome | Completed | 09/2019 ... | Biogen |
| Nurown | Active Not Recruiting | 12/2020 | Brainstorm |
| Perampanel | Recruiting | Eisai, Beirut and US | |
| Pimozide | Recruiting | 12/2019 ... | University of Calgary |
| Q-cells | Not Yet Recruiting | 12/2020 | Q Therapeutics |
| Rapamycin | Active Not Recruiting | 09/2019 ... | Univ Modena |
| Ravulizumab | Recruiting | 10/2024 | Alexion |
| RNS60 | Active Not Recruiting | 01/2022 | Italy and US |
| Ropinorole | Recruiting | 03/2021 | Japan |
| SOD1-antisense BIIB067 | Recruiting | 07/2021 | Biogen/Ionis |
| Tocilizumab | Completed | 07/2018 ... | Barrow Institute |
| Trametinib (SNR1611) | Recruiting | 03/2022 ... | Genuv |
| Tregs | Active Not Recruiting | 11/2023 | Dr Stanley Appel NEALS |
| TUDCA | Recruiting | 06/2022 | horizon 2020 |
